← All organizations

Anchen Pharmaceuticals, Inc

For profit

Also known as: ANCHEN PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Sep 1, 2011

Acquired by Par Pharmaceuticals → Endo Pharmaceuticals → Mallinckrodt (2013) on Aug 24, 2011

Timeline

2000s

Jun 1, 2004
Anchen Pharmaceuticals, Inc— Founded

2010s

Aug 24, 2011
Par Pharmaceuticals— Acquired By
Dec 1, 2017
quetiapine— Marketing Organization

2020s

Mar 1, 2025
Mallinckrodt (2013)— Now

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (2)

NCT01456611Lead sponsorPhase 3Sep 1, 2011
NCT01372423Lead sponsorPhase 3May 1, 2011

Details

Founded: Irvine, CA, US Jun 1, 2004
Last known activity: Sep 1, 2011